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We reviewed the published epidemiologic studies addressing the relationship between workplace
exposure to environmental tobacco smoke (ETS) and cardiovascular disease risk in three
case-control studies and three cohort studies. Although the point estimates of risk for
cardiovascular disease exceeded 1.0 in five of six studies, none of the relative risks was statistically
significant because of the small number of cardiovascular end points occurring in individual studies.
In common with most epidemiologic investigations of the health risks of ETS, none of the
workplace studies included independent biochemical validation of ETS exposure. In contrast to the
evidence on increased cardiovascular disease risk from exposure to spousal ETS, studies of ETS
exposure in the workplace are still sparse and inconclusive. Conversely, there is no biologically
plausible reason to believe that the hazards of ETS exposure that have been demonstrated in the
home should not also apply to the workplace. Key words: cardiovascular disease, environmental
tobacco smoke, passive smoking, tobacco smoke pollution. - Environ Health Perspect 107(suppl
6):847-851 (1999).
http.//ehpnetl.niehs.nih.gov/docs/1999/suppl-6/847-851kawachi/abstract.html
Epidemiologic Studies of
Workplace Exposure to
Environmental Tobacco
Smoke and Cardiovascular
Disease
This article reviews the methods and find-
ings ofpublished studies addressing the rela-
tionship between workplace exposure to
environmental tobacco smoke (ETS) and
the risk of cardiovascular disease. Using the
MEDLINE database (National Library of
Medicine, Bethesda, MD), we conducted a
search of the published peer-reviewed litera-
ture linking ETS to cardiovascular disease.
All studies located in this database were
reviewed to determine if the investigators
specifically examined workplace exposure to
ETS. We identified six published epidemio-
logic studies-three case-control studies
(1-3) and three cohort studies (4-6)-that
examined the relationship between ETS
exposure in the workplace and risk of
cardiovascular disease.
Considering current exposure to ETS in
the workplace, the point estimates of the
odds ratios/relative risks for cardiovascular
disease exceeded 1.0 (range, 1.2-1.9) in five
of the six studies, although none of the esti-
mates was statistically significant (Table 1,
Figure 1). The imprecision of the risk esti-
mates (with the exception of the large
American Cancer Society CPS-II cohort)
(5) reflects the relatively small number of
cardiovascular events occurring in the
individual studies.
Recently, Wells (7) reported a meta-
analysis of the published and unpublished
studies on the relationship ofpassive smok-
ing in the workplace and risk ofcardiovascu-
lar disease. In addition to the six published
studies included in this survey (1-6), the
meta-analysis by Wells included data from
two unpublished doctoral dissertations
(8,9). These eight studies yielded a pooled
relative risk estimate of 1.18 (95% confi-
dence interval [CI], 1.04-1.34) (7). Since
the purpose ofthe present review was not to
replicate Wells' meta-analysis, we will not
further consider the unpublished disserta-
tions. We will review the six published
studies (1-6) from the perspective of their
adequacy in measuring ETS exposure at
work, addressing issues ofconfounding, and
assessing dose-response relations.
Assessment of ETS Exposure
Environmental tobacco smoke exposure was
assessed in all studies by interview (case-con-
trol studies) or self-completed questionnaire
(cohort studies). With the exception of the
case-control study by Dobson et al. (1), none
ofthe studies included biochemical validation
ofETS exposure. Dobson et al. (1) measured
plasma fibrinogen levels while ascertaining
ETS exposure. They reported higher fibrino-
gen levels among individuals reporting ETS
exposure than among those reporting no
exposure, although the differences were not
statistically significant. Investigators in only
two of the six studies (2,6) sought and
reported information regarding the intensity
ofexposure to ETS at work (Table 2). Both
studies reported a dose-response relation
between higher intensity of ETS exposure in
the workplace and risk ofcardiovascular dis-
ease. In only two of the six studies (2,3),
information was collected and analyzed on
the duration ofexposure to ETS in the work-
place, and neither study found an association
between increasing duration ofexposure and
risk ofcardiovascular disease.
Several types ofexposure misclassification
could have potentially occurred in the six
cited studies (10):
* Misclassification of smokers falsely
reporting themselves to be nonsmokers.
This type of misclassification is believed
to be minor. For example, the proportion
of individuals in observational studies
who falsely report not smoking but who
are assessed to be smokers by cotinine or
nicotine measurement in body fluids
ranges from 1-4% (11).
* Under- or overestimation ofETS exposure
among nonsmokers. The extent to which
recall bias might result in overestimation
ofETS exposure in case-control studies is
unknown. Generally, nonsmokers are
more likely to underestimate their extent
of ETS exposure. For example, in a study
of663 never smokers and former smokers
attending a cancer screening clinic, 91%
had detectable levels ofcotinine in their
urine even though only 76% ofsubjects
reported ETS exposure in the previous 4
days (12). Although there are dietary and
other noninhaled sources ofnicotine, these
are likely to make a negligible contribution
to cotinine levels (13,14).
* Inaccuracy of self-reported intensity of
exposure to ETS. Self-reported current
exposure to passive smoking correlates
only modestly (Pearson coefficients rang-
ing between 0.2 and 0.5) with biochemi-
cal markers such as salivary (12) and
urinary (15) cotinine. This is likely to
result in a bias toward the null in estimates
ofdose-response relations between inten-
sity ofETS exposure and risk ofdisease.
* Downward secular trends in ETS
exposure. The prevalence ofpassive smok-
ing has declined during the past decade in
countries such as the United States since
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Table 1. Summary of studies examining current exposure to ETS in the workplace in relation to cardiovascular
disease risk.
No. of Crude OR/RR Adjusted OR/RR
Study (reference) cases (95% Cl) (95% Cl) Confounders adjusted for
Case-control studiesa
Dobson etal., M 27 0.90 (0.50-1.60) 0.95(0.51-1.78) Age, past history of coronary
1991 (1) F 5 0.71 (0.19-2.27) 0.66 (0.17-2.62) heart disease
He et al., F 33 2.45 (1.23-4.88) 1.85(0.86-4.10) Age, hypertension, type A, serum
1994(2) total, cholesterol, high-density
lipoprotein, ETS from spouse
Muscat and M 44 Not stated 1.2 (0.6-2.2) Age, education, hypertension
Wynder, 1995(3) F 20 Not stated 1.0(0.4-2.5)
Cohort studiesb
Svendsen etal., M 69 1.4(0.80-2.50) Not stated Age, wife's smoking status
1987(4)
Steenland etal., M 768 Not stated 1.03(0.89-1.19) Hypertension, diabetes, BMI,
1996(5) F 319 Not stated 1.06(0.84-1.34) education, aspirin use, alcohol,
exercise, employment status
Kawachi et al., F 64 1.53c(0.73-3.18) 1.49(0.71-3.14) Age, hypertension, diabetes,
1997 (6) 2.16d(1.02-4.58) 1.92 (0.88-4.18) hypercholesterolemia, BMI,
aspirin use, alcohol, vitamin E,
BMI, PMH use, menopausal
status, past oral contraceptive
use, saturated fat intake,
family history of myocardial
infarction, father's occupation
Abbreviations: BMI, body mass index; F, female; M, male; OR, odds ratio; PMH, postmenopausal hormone; RR, relative risk. &Exposed
cases. bCardiovascular cases. cOccasional ETS exposure. dRegular ETS exposure.
increasing numbers ofpeople have stopped
smoking and more workplaces have
become smoke free. Cohort studies that
assessed ETS exposure in the 1970s and
mid-1980s, and only once at baseline
(4-6) (Table 3), would continue to count
individuals as exposed even though expo-
sure ceased during the course ofthe study
and these individuals presumably benefited
from reduced risks ofcardiovascular dis-
ease. In otherwords, these studies probably
have underestimated the riskofdisease.
Confounding
Individuals exposed to passive smoking at
home are less healthy with respect to other
lifestyle habits compared to unexposed indi-
viduals (10,16,17). However, little has been
documented about differences in health
habits comparing those individuals exposed
to ETS in the workplace to those not
exposed. It is likely, however, that voluntary
restrictions on workplace smoking are less
common in blue-collar occupations and that
workers employed in these jobs tend to have
fewer health-conscious health habits than
white-collar workers.
Given the relatively modest associations
between passive smoking and cardiovascular
disease, it is important to exclude confound-
ing as an explanation for the observed associa-
tion. Of the studies that examined ETS
exposure in the workplace and cardiovascular
disease, only three (2,5,6) managed to adjust
for a reasonably broad range of potential
confounding factors (Table 1). In all three
studies, adjustment for confounding factors
resulted in some reduction of the risk esti-
mates. In the case-control study by He et al.
(2), adjustment for multiple risk factors for
cardiovascular disease (including history of
hypertension, type A personality, total and
high-density lipoprotein [HDL] cholesterol
levels, and passive smoking at home) resulted
in a 24% reduction in the odds ratio for car-
diovascular disease. However, to the extent
that a reduction in HDL cholesterol may lie
in the causal pathway between passive smok-
ing and cardiovascular disease (18), adjusting
for this variable may have resulted in statisti-
cal overcontrol. However, because only the
final adjusted model was presented in the
study by He et al. (2), it was not possible to
assess the extent of this problem. In two
cohort studies (5,6), adjustment for con-
founding resulted in a very modest reduction
(2-11%) in the relative risks (Table 1).
Overall, unadjusted confounding is believed
to result in a small bias in overestimating the
risk of passive smoking on cardiovascular
disease (10,18,19).
Ascertainment of Disease
End Points
In total, the evidence on ETS exposure in the
workplace and risk ofcardiovascular disease is
based upon 1,594 end points, to which the
American Cancer Society CPS-II cohort (5)
contributed 68% ofcases (Table 3). The six
studies used different definitions of
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Figure 1. Studies of ETS exposure in the workplace and
cardiovascular disease. Point estimates of odds
ratios/relative risks and 95% confidence intervals.
Abbreviations: F, female; M, male; occ, occasional expo-
sure to workplace ETS; reg, regular exposure to work-
place ETS.
cardiovascular disease end points. Three
studies used World Health Organization
(WHO) criteria (i.e., symptoms plus either
cardiac enzyme level elevations or diagnostic
electrocardiogram changes) (20) to confirm
cardiovascular disease end points (1,2,6); two
studies (3,5) used the International
Classification ofDiseases, 9th revision codes
(21); in one case, the Multiple Risk Factor
Intervention Factor study (4) used internal
criteria developed by a panel ofcardiologists
and physicians. Four studies (2-4,6)
restricted their end points to incident events
occurring among subjects free ofa history of
heart disease; two studies (1,5) included dis-
ease events occurring among those with a his-
tory ofheart disease. Forty-two percent ofthe
end points in the study by He et al. (2) com-
prised cases of myocardial infarction con-
firmed by WHO criteria; the remainder
(58%) comprised cases ofcoronary stenosis
(> 50% occlusion) diagnosed byangiography.
It is possible that such variations in the defin-
ition ofend points mayhave led to discrepan-
cies in the association ofpassive smoking and
coronary disease. Despite the heterogeneity in
case definition, however, we discerned no
obvious pattern of differences in results
according to the end point adopted. None of
the six studies reported relationships ofETS
exposure in the workplace to other cardiovas-
cular disease end points such as stroke or
peripheral vascular disease.
Dose-Response Relations
between ETS Exposure and
Risk ofCardiovascular Disease
IntensityofETSExosure in the
Workplace
Only two studies collected information on
intensity ofETS exposure in the workplace.
He et al. (2) assessed the number ofsmoking
co-workers, the estimated number ofcigarettes
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smoked per day, and the average duration of
exposure (number ofhours per day). Kawachi
et al. (6) asked respondents to self-rate their
exposure at work as "never," "occasional," or
"regular." Steenland et al. (5) also asked about
the number ofhours per day ofETS exposure
in the workplace but did not report their find-
ings. Both the case-control study by He et al.
(2) and the study by Kawachi et al. (based on
the Nurses' Health study) (6) found evidence
ofdose-response relations between intensity of
ETS exposure in the workplace and risk of
cardiovascular disease (Table 4).
Duration ofETS Exposure inthe
Workplace
Duration ofETS exposure in the workplace
was assessed in only two studies. He et al. (2)
requested number ofyears of exposure at
work; Muscat and Wynder (3) requested
number ofyears of exposure to ETS as an
adult but did not separate home exposure
from work exposure. In the case-control
study by He et al. (2), none of the women
had been exposed for less than 5 years. Both
the American Cancer Society CPS-II cohort
(5) and the Nurses' Health study (6) asked
about duration ofexposure to spousal smok-
ing but did not assess duration to workplace
ETS exposure. He et al. (2) did not find a
statistically significant trend between duration
of ETS exposure and risk of cardiovascular
disease; Muscat and Wynder (3) concluded
that there was no trend between duration and
risk of heart disease, although they did not
report a formal test for trend (Table 4).
The Discrepancybetween
Dose-Response Relations Comparing
Intensityto Duration
The discrepancy between dose-response
trends comparing intensity and duration of
ETS exposure may result from greater mis-
classification ofcumulative duration ofexpo-
sure compared to assessment of current
Table 2. Environmental tobacco smoke exposure assessment in studies of exposure in the workplace and risk of car-
diovascular disease.
Method of Prevalence of
Study (reference) assessment exposure Comments
Case-control studiesa
Dobson et al.,
1991 (1)
He et al., 1994(2)
Muscat and
Wynder, 1995 (3)
Cohort studiesb
Svendsen et al.,
1987 (4)
In-hospital interview
(nonfatal myocardial
infarction)
Duestionnaires sentto
relatives (fatal
coronary heart disease)
Standardized interview
In-hospital interview
Baseline questionnaire
(1973)
Steenland et al., Baseline questionnaire
1996 (5) (1982)
Home
M 13%
F 19%
Work
M 44%
F 37%
Home
F 45%
Work
F 32%
Home
M not stated
F 24%
Work
M 61%
F 44%
Home
M 20%
Work
M 73%
Home
M 19%
F 28%
Work
Not stated
Kawachi et al., Baseline questionnaire Home
1997 (6) (1982) F 42%
Work
F 78%
(66% occasional,
33% regular)
&Prevalence of exposure in smokers. bPrevalence of exposure in nonsmokers.
No data on intensity/duration of
exposure
Plasma fibrinogen measured at
same time
Ascertained intensity (no. of smokers;
no. of cigarettes smoked/day by
others; no. of hours exposed/day)
and duration (no. of years exposed)
Intensity showed dose-response
relation to disease risk; duration
did not
No biochemical validation
Test-retest interview conducted
in 33% of cases; 74% agreement
for passive smoking atwork
No data on intensity
Duration ascertained but not analyzed
separately from home exposure
No biochemical validation
No updating of exposure during 8-yr
follow-up
Workplace ETS exposure assessed by
asking subjects about smoking
status of "most of their co-workers"
No updating of exposure during 8-yr
follow-up
Assessed intensity (no. of hours per
day), but not reported
28% of men and 48% of women
missing data on ETS exposure at
work; excluded from analyses
No updating of exposure during 10-yr
follow-up
Assessed intensity but not duration
of exposure atwork
Intensity showed dose-response
relation
Table 3. Cardiovascular disease end points examined in studies of ETS exposure in theworkplace.
Study(reference) End points Confirmatory criteria Comments
Dobson et al., 1991 (1) Nonfatal myocardial infarction WHO criteria No breakdown of causes
Coronary death (n= 201 total)
Included cases among those with
history of coronary heart disease
He etal., 1994(2) Nonfatal myocardial infarction (n=25); WHO criteria Incident cases
> 50% coronary stenosis (n= 34) Angiography
Muscat and Wynder, 1995 (3) Nonfatal myocardial infarction (n = 114) ICD-9 code 410.0a Incident cases
Svendsen et al., 1987 (4) Fatal (n = 13) or nonfatal (n=56) Classified by threecardiologists, based Incident cases
coronary heart disease on review ofhospital records, autopsy
reports, death certificates
Steenland et al., 1996 (5) Coronary heart disease death (n= 1,087) Death certificates coded to ICD-9 Included 5-10% cases with history
(codes 410-414)a of coronary heart disease
Kawachi et al., 1997 (6) Nonfatal myocarcial infarction (n =52); WHO criteria Incident cases
fatal coronary heart disease (n= 12) Death certificates
8lnternational Classification ofDiseases, 9th revision (21).
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Table 4. Dose-response relations (intensity and duration) between ETS exposure in the workplace and cardiovascular Workplace Exposure
diseaserisk. Contrasted to Home Exposure
No. of
Study (reference) Exposure category exposed cases Adjusted OR/RR p, trend
Intensity
He et al., 1994 (2) No. of cigarettes smoked/
day by co-workers
0-5 (actually 0) 26 1.00
6-10 10 0.87 (0.30-2.53)
1 1-20 15 2.95 (1.05-8.28)
20+ 8 3.56 (0.81-15.6) 0.02
No. of smoking co-workers
0 26 1.00
1-2 16 1.16 (0.48-2.82)
3 12 5.06 (1 .42-18.0)
4+ 5 4.11 (0.39-43.7) 0.02
No. of hours/day
0 26 1.00
1-2 8 0.62 (0.22-1.80)
3-4 15 4.03 (1.33-12.3)
5+ 10 21.3 (2.71-168) 0.002
Kawachi et al., 1997 (6) Never 9 1.00
Occasional 32 1.49 (0.71-3.14)
Regular 23 1.92 (0.88-4.18) 0.04
Duration
He et al., 1994 (2) No. of years exposed
0-5 (actually 0) 26 1.00
6-15 8 3.08 (0.90-10.6)
16+ 25 1.56 (0.67-3.64) 0.12
Muscat and Wynder, 1995 (3)a No. of years exposed
Male
0 38 1.0
1-20 12 1.7 (0.7-4.5)
21-30 5 1.5 (0.4-5.2)
31+ 13 1.1 (0.4-2.8) NS
Female
0 13 1.0
1-20 12 2.0 (0.5-8.1)
21-30 5 0.9 (0.2-4.4)
31+ 16 1.7 (05-5.9) NS
NS, not stated. aCombined exposure to ETS in the home and workplace.
intensity of exposure and/or the possibility
that ETS increases cardiovascular disease risk
via acute mechanisms so that increasing
duration of exposure does not contribute to
further increases in risk.
In assessment of current ETS exposure
compared to cumulative duration of expo-
sure, Pron et al. (22) found that self-reported
duration ofexposure was less reliable than the
assessment of recent passive smoking expo-
sure. In that study, a correlation coefficient of
0.25 was found between the reported dura-
tions of exposure to spousal smoking at the
initial and repeat interviews. When misclassi-
fication ofexposure duration is minimized, it
may be possible to observe a dose-response
relation to cardiovascular disease risk. For
example, Steenland et al. (5) found evidence
for a dose-response relation between duration
of home exposure to ETS and risk ofcardio-
vascular disease risk when their analysis was
restricted to the subgroup of the American
Cancer Society CPS-II cohort in whom
reports of exposure to ETS were concordant
for both self-reports and spousal reports.
Alternatively, some authors have
suggested that the mechanisms by which
ETS increases the risk of cardiovascular dis-
ease are short-term (in which case, increas-
ing duration of ETS exposure may not
produce increasing risk of disease). On the
basis of data from published experimental
studies, Law et al. (23) calculated effects of
tobacco smoke exposure on platelet aggrega-
tion. In experiments, exposure to second-
hand smoke for 20 min resulted in a
1.03-standard deviation increase in platelet
aggregation, whereas actually smoking one
to two cigarettes was associated with about a
1.25-standard deviation increase (24). The
effect oftobacco smoke exposure on platelet
aggregation is believed to be acute; 1 hr after
a single exposure, the effect on platelet
aggregation is nearly halved. Working from
this experimental evidence, Law et al. (23)
calculated that repeated exposure to tobacco
smoke throughout the day (such as experi-
enced by a regular passive smoker) could be
consistent with a 20-30% elevation in risk
ofcardiovascular disease.
For both men and women, the prevalence of
exposure to ETS in the workplace was sub-
stantially higher than in the home in these six
studies (Table 2). The sole exception was the
study from China by He et al. (2) in which
women reported a higher prevalence ofexpo-
sure to ETS at home than at work. None of
the studies assessed the intensity of ETS
exposure at home and in the workplace, so
that it is possible that home exposure may be
more intense than workplace exposure
(25,26). Conversely, environmental monitor-
ing studies suggest that for many groups of
workers occupational exposure may involve a
higher density ofsmokers in the immediate
environment (27,28). Additionally, many
individuals spend more time at work than in
the company oftheir spouses at home.
Despite the higher prevalence of ETS
exposure in the workplace than in the home,
the evidence linking ETS to cardiovascular
disease is more consistent and abundant for
home exposure. The reason for the wealth of
evidence for home exposure is because many
epidemiologic studies have been able to use
proxy measures of exposure to spousal
tobacco smoke (i.e., using "married to a
smoker" as an indicator of ETS exposure at
home). The point estimates for home and
workplace exposure are similar, however, and
the 95% CI values overlap in most cases. For
example, in the study by Kawachi et al. (6),
among women exposed only at work and not
at home, the adjusted relative risks of total
coronary heart disease (CHD) were 1.49
(95% CI, 0.71-3.14) among those occasion-
ally exposed and 1.92 (95% CI, 0.88-4.18)
among those regularly exposed to ETS.
Among women exposed only at home and not
at work, the corresponding adjusted relative
risks were 1.19 (95% CI, 0.63-2.31) and 2.11
(95% CI: 1.03-4.33). In the case-control
study by He et al. (2), the adjusted odds ratio
ofcoronary disease among women exposed to
ETS at home was 1.24 (95% CI, 0.56-2.72)
compared to 1.85 (95% CI, 0.86-4.00) for
exposure in the workplace. He et al. (2) also
reported additive effects ofhome and work-
place exposure on risk ofcoronary disease.
A potential problem in contrasting home
and workplace exposure is the handling of
simultaneous exposure in both settings. In the
study by Kawachi et al. (6), women reporting
any ETS exposure at home were excluded
from the workplace analyses and vice versa. In
the case-control study by He et al. (2), analy-
ses ofworkplace ETS statistically adjusted for
home exposure. However, in the remaining
three studies (1,3,5), it is unclear how the
investigators handled simultaneous exposure;
i.e., there may have been some misclassification
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of exposure if a proportion of individuals
were exposed in both settings, and this was
not taken into account.
Effects ofWorkplace ETS
Exposure in Population
Subgroups
Gender
Ofthe 1,594 end points included in the five
studies, 515 (32%) occurred among women.
Five studies (1-3,5,6) included women
(Table 1); four studies (1,3-5) included men.
The data are too sparse to draw any conclu-
sions about gender differences in risk ofETS
exposure in theworkplace.
Social Class
Steenland et al. (5) conducted separate analyses
for blue-collar and white-collar workers and
found that passive smoking in the workplace
was related to CHD risk only in male blue-
collar workers (adjusted relative risk, 1.36;
95% CI, 1.01-1.83). ETS exposure was not
related to CHD risk among white-collar
workers, male or female.
FormerSmokers
Dobson et al. (1) analyzed the risks ofETS
exposure in theworkplace separately for never
smokers and former smokers and found no
relationship between passive smoking and risk
of CHD among either group for males.
Among females, the adjusted odds ratios of
CHD from ETS exposure was 0.66 (95% CI,
0.17-2.62) among never smokers and 2.21
(95% CI, 0.33-14.9) among former smokers.
However, as the width ofthe 95% CI values
attests, the analyses amongwomen were based
on a fewexposed cases (five each among never
smokers and formersmokers) (1).
Conclusions
In contrast to the evidence on spousal
exposure to ETS and cardiovascular disease,
studies ofETS exposure in the workplace are
still sparse and inconclusive. Although the
point estimates ofrisk for cardiovascular dis-
ease exceeded 1.0 in five ofsix studies, none
ofthe relative risks was statistically significant
because ofthe small number ofcardiovascular
end points occurring in individual studies
(except for the American Cancer Society
CPS-II study). All the published studies
assessed ETS exposure in the workplace by
self-report (interviews or questionnaires). In
common with most epidemiologic studies of
ETS, none ofthe workplace studies provided
independent biochemical validation ofETS
exposure. However, most exposure misclassi-
fications in these studies are likely to be
minor and may have introduced a conserva-
tive bias in the estimation ofrisk. Potential
confounding is possibly a more important
issue in studies ofcardiovascular disease than
in studies oflung cancer, but three ofthe six
published studies adjusted for a broad range
ofpotential confounding factors, and two of
these found evidence ofincreased risk ofcar-
diovascular disease with ETS exposure in the
workplace. Further studies are needed to con-
clusively demonstrate an effect ofETS expo-
sure in the workplace on cardiovascular
disease risk. In particular, studies are needed
to relate the intensity and duration of ETS
exposure at work to cardiovascular disease
risk. Despite the sparsity of evidence on
workplace exposure, however, there is little
biologically plausible reason to believe that
the hazards ofETS exposure that have been
demonstrated in the home setting should not
also applyto theworksetting.
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